207 related articles for article (PubMed ID: 6332992)
1. Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells.
Bennink JR; Yewdell JW; Smith GL; Moller C; Moss B
Nature; 1984 Oct 11-17; 311(5986):578-9. PubMed ID: 6332992
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immune responses to influenza virus antigens expressed by vaccinia virus recombinants.
Andrew ME; Coupar BE; Ada GL; Boyle DB
Microb Pathog; 1986 Oct; 1(5):443-52. PubMed ID: 3509883
[TBL] [Abstract][Full Text] [Related]
3. Characterization of antibody and cytotoxic T lymphocyte responses to human influenza virus H3 haemagglutinin expressed from the haemagglutinin locus of vaccinia virus.
Itamura S; Iinuma H; Shida H; Morikawa Y; Nerome K; Oya A
J Gen Virol; 1990 Dec; 71 ( Pt 12)():2859-65. PubMed ID: 2273387
[TBL] [Abstract][Full Text] [Related]
4. Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response.
Coupar BE; Andrew ME; Both GW; Boyle DB
Eur J Immunol; 1986 Dec; 16(12):1479-87. PubMed ID: 3493144
[TBL] [Abstract][Full Text] [Related]
5. The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants.
Andrew ME; Coupar BE; Boyle DB; Ada GL
Scand J Immunol; 1987 Jan; 25(1):21-8. PubMed ID: 3492756
[TBL] [Abstract][Full Text] [Related]
6. Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes.
Blake NW; Kettle S; Law KM; Gould K; Bastin J; Townsend AR; Smith GL
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2393-8. PubMed ID: 7561783
[TBL] [Abstract][Full Text] [Related]
7. A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus.
Sutter G; Wyatt LS; Foley PL; Bennink JR; Moss B
Vaccine; 1994 Aug; 12(11):1032-40. PubMed ID: 7975844
[TBL] [Abstract][Full Text] [Related]
8. Recombinant vaccinia virus: immunization against multiple pathogens.
Perkus ME; Piccini A; Lipinskas BR; Paoletti E
Science; 1985 Sep; 229(4717):981-4. PubMed ID: 2992092
[TBL] [Abstract][Full Text] [Related]
9. Homotypic and heterotypic protection against influenza virus infection in mice by recombinant vaccinia virus expressing the haemagglutinin or nucleoprotein of influenza virus.
Endo A; Itamura S; Iinuma H; Funahashi S; Shida H; Koide F; Nerome K; Oya A
J Gen Virol; 1991 Mar; 72 ( Pt 3)():699-703. PubMed ID: 2005435
[TBL] [Abstract][Full Text] [Related]
10. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
[TBL] [Abstract][Full Text] [Related]
11. [Design of a recombinant strain of the vaccinia virus containing an expressible gene for influenza A virus hemagglutinin].
Gibadulin RA; Lazarenko AA; Iuferov VP; Lideman LF; Denisova GF
Vopr Virusol; 1988; 33(3):275-8. PubMed ID: 3176425
[TBL] [Abstract][Full Text] [Related]
12. Successful vaccination with a polyvalent live vector despite existing immunity to an expressed antigen.
Flexner C; Murphy BR; Rooney JF; Wohlenberg C; Yuferov V; Notkins AL; Moss B
Nature; 1988 Sep; 335(6187):259-62. PubMed ID: 2842693
[TBL] [Abstract][Full Text] [Related]
13. Biological and immunological characterization of influenza virus haemagglutinin expressed from the haemagglutinin locus of vaccinia virus.
Itamura S; Morikawa Y; Shida H; Nerome K; Oya A
J Gen Virol; 1990 Jun; 71 ( Pt 6)():1293-301. PubMed ID: 2351957
[TBL] [Abstract][Full Text] [Related]
14. Recombinant vaccinia viruses and the development of immunization strategies using influenza virus.
Doherty PC; Allan W; Boyle DB; Coupar BE; Andrew ME
J Infect Dis; 1989 Jun; 159(6):1119-22. PubMed ID: 2786041
[No Abstract] [Full Text] [Related]
15. Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes.
Bennink JR; Yewdell JW; Smith GL; Moss B
J Virol; 1986 Mar; 57(3):786-91. PubMed ID: 3485199
[TBL] [Abstract][Full Text] [Related]
16. Influenza A virus-specific H-2d restricted cross-reactive cytotoxic T lymphocyte epitope(s) detected in the hemagglutinin HA2 subunit of A/Udorn/72.
Saikh KU; Martin JD; Nishikawa AH; Dillon SB
Virology; 1995 Dec; 214(2):445-52. PubMed ID: 8553546
[TBL] [Abstract][Full Text] [Related]
17. Cross-protection against microvariants of influenza virus type B by vaccinia viruses expressing haemagglutinins from egg- or MDCK cell-derived subpopulations of influenza virus type B/England/222/82.
Rota PA; Shaw MW; Kendal AP
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1533-7. PubMed ID: 2732722
[TBL] [Abstract][Full Text] [Related]
18. Recombinant vaccinia immunization in the presence of passively administered antibody.
Johnson MP; Meitin CA; Bender BS; Small PA
Vaccine; 1993; 11(6):665-9. PubMed ID: 8322491
[TBL] [Abstract][Full Text] [Related]
19. Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression.
Flexner C; Hügin A; Moss B
Nature; 1987 Nov 19-25; 330(6145):259-62. PubMed ID: 3118219
[TBL] [Abstract][Full Text] [Related]
20. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice.
Wild TF; Bernard A; Spehner D; Drillien R
J Gen Virol; 1992 Feb; 73 ( Pt 2)():359-67. PubMed ID: 1538193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
